Navigation Links
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
Date:6/17/2011

NMS.

Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with RISPERDAL® and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.

RISPERDAL® and similar medications can raise the blood levels of a hormone known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin remain elevated with continued use. Some side effects seen with these medications include the absence of a menstrual period; breasts producing milk; the development of breasts by males; and the inability to achieve an erection. The connection between prolactin levels and side effects is unknown.

High blood sugar and diabetes have been reported with RISPERDAL® and similar medications. If the person being treated has diabetes or risk factors such as being overweight or a family history of diabetes, blood sugar testing should be performed at the beginning and throughout treatment. Complications of diabetes can be serious and even life threatening. If signs of high blood sugar or diabetes develop, such as being thirsty all the time, going to the bathroom a lot, or feeling weak or hungry, contact your doctor.

RISPERDAL® should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.

Some people taking RISPERDAL® may feel faint or lightheaded when they stand up or sit up too quickly. By standing up or sitting up slowly and following your healthcare professional's dosing inst
'/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
2. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
3. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
4. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
5. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
6. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
7. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
8. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
9. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
10. Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 Every ... more research to fight heart disease.  Nevertheless, year after ... on ElectroCardioGrams (EKG) as the first test to determine ... they have chest pain or not, even though that ... occurs despite the fact that doctors know, (while most ...
(Date:2/26/2015)... Feb. 26, 2015 Research and Markets ... "Radiation Therapy Equipment - Global Strategic Business Report" ... report analyzes the worldwide markets for Radiation Therapy Equipment ... Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. The ... Canada , Japan , ...
(Date:2/26/2015)... 2015  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of Hepatitis B virus (HBV) and other viral ... million financing. Funds from this financing will accelerate ... spectrum antiviral agent derived from Spring Bank,s ... platform, into Phase II clinical trials for the ...
Breaking Medicine Technology:National Heart Health Month In February 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... standard has replaced the Statement on Auditing Standards No. ... Standards for Attestation Engagements No. 16 (SSAE 16), became ... to enforce a stronger set of controls and more ... Rising Medical Solutions has taken the first ...
... ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced ... Global Healthcare Conference in London. Dr. Ramin Mojdeh, Executive ... to present at 5:00 p.m. British Summer Time (12:00 ... The conference presentation will be broadcast over the ...
Cached Medicine Technology:Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 2Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 3Unilife to Present at the Jefferies 2011 Global Healthcare Conference in London 2
(Date:2/27/2015)... According to court documents, Donna Pirolli was a ... and underwent a procedure during which a duodenoscope was ... the duodenoscope allegedly had not been properly cleaned, Donna ... (CRE). , A lawsuit has been proceeding ... of Ms. Pirolli alleging that Lutheran General Hospital was ...
(Date:2/27/2015)... Winter is here, and with it comes harsh snow ... and ice can be harmful on a dog’s paws. Commonly ... Store is ready to help pet owners know what to ... winter time. , Ice melts can lead to several health ... of ice melt products may cause depression, loss of appetite, ...
(Date:2/27/2015)... February 27, 2015 FACE Skincare~Medical~Wellness, ... has announced a unique combination to take fifteen ... Ultherapy Décolletage is a new treatment introduced that ... procedure specifically indicated to improve lines and wrinkles ... any person who suffers from the stubborn vertical ...
(Date:2/27/2015)... California (PRWEB) February 27, 2015 ... announced today the launch of its CloudPoint™ ... enabling the digital production of monolithic zirconia crowns ... affordable means of providing the CAD/CAM-produced restorations that ... digital portal through which cases can be scanned, ...
(Date:2/27/2015)... 2015 Insight Accelerator Labs has ... the development of an in-line urine flow meter ... being developed in direct response to current high ... and error margins with potentially grave consequences. The ... and provide trending data analysis to signal ICU ...
Breaking Medicine News(10 mins):Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3
... ... ... continuing to offer H1N1 nasal vaccines and H1N1 vaccine shots at four Centegra Primary Care (CPC) ... Huntley, Woodstock, Crystal Lake and McHenry and will be open as follows: , ...
... , ARLINGTON, Va., Nov. 25 The American ... Act of 2009," S. 2128, which is designed to substantially ... The bill was introduced by Sen. George LeMieux (R-Fla.). , ... Homecare outlined in its 13-point anti-fraud action plan, which the ...
... under the skin kill tumor cells, study finds , ... delivered in a fingernail-size implant eliminated melanoma tumors in ... polymer disks, 8.5 millimeters in diameter, that are loaded ... reprogram the immune system to attack tumors. The Harvard ...
... , WASHINGTON, Nov. 25 The Advisory Board ... participate in the 21st Annual Piper Jaffray Health Care Conference ... December 2, 2009 at 3:00 PM (EST), will be the ... Chief Financial Officer, Michael T. Kirshbaum. The presentation materials ...
... , AVENTURA, Fla., Nov. 25 Daniel Touizer, CEO of ... nationwide provider of guaranteed issue health insurance benefit programs, is concerned that the ... without a full-time job and unlikely to have health insurance. ... to 17.5%, the highest rate in over 20 years," says Dani ...
... 25, 2009) Melvin R. Kaplan, MD, FACP, a former ... institute that became Los Angeles Biomedical Research Institute at Harbor-UCLA ... College of Physicians for his lifetime devotion to the care ... Toronto, the American College of Physicians will present Dr. Kaplan ...
Cached Medicine News:Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:1 of LA BioMed's founders to be honored 2
Inquire...
Inquire...
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: